Ideal candidates for Semaglutide and Tirzepatide treatments are individuals who are struggling with weight loss despite efforts with diet and exercise or those who have a medical need to lose weight to reduce the risks associated with obesity-related conditions
What works optimally for one individual may require adjustments for another
and Canada compared to other parts of the world, enabling more patients to access costly drugs such as GLP-1 receptor agonists
Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B
These symptoms are more concerning when they are severe, persistent, or paired with dizziness, dark urine, confusion, fainting, or inability to keep fluids down
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients